8-10% sustainable growth over 2-3 years
Management targets a return to 8-10% revenue growth over the next 2-3 years, driven by new products and market recovery.
INSECTICID / guidance tracker
Keep management guidance in view.
Insecticides (India) · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
growth
Five new product launches in Q1 FY27
At least five new products will be launched in Q1 FY27, including three exclusive products and two generics.
Dahej formulation plant operational in Q1 FY27
The new formulation facility at Dahej is expected to start operations in Q1 FY27, with the technical plant following in FY27.
Double-digit EBITDA margin for FY26
Management expects to end FY26 with double-digit EBITDA margins, despite pressure in H2.
Revenue growth expected to be positive in FY27
Management expects both top line and bottom line to be positive in FY27, with results visible from Q1 itself, though dependent on monsoon.
Capex to remain nominal at ₹25-30 crore in FY27
Once current projects are completed in FY27, capex will be limited to maintenance levels of ₹25-30 crore.
Finance cost reduction target of 25-30% in FY27
Management targets reducing finance costs by 25-30% in FY27 through better working capital management.
Kyros revenue expected to double in FY27
The subsidiary Kyros, which had ~₹6 cr revenue in FY26, is expected to at least double sales in FY27 as the brand launches.